D. H. Szolar, M. Korobkin, P. Reittner, A. Berghold, T. Bauernhofer, H. Trummer, H. Schoellnast, K. W. Preidler and H. Samonigg, “Adrenocortical Carcinomas and Adrenal Pheochromocytomas: Mass and Enhancement Loss Evaluation at Delayed Contrast-Enhanced CT,” Radiology, Vol. 234, No. 2, 2005, pp. 479-485. doi:10.1148/radiol.2342031876

has been cited by the following article:

• TITLE: Multi-Detector-Row CT Diagnosis of Adrenal Incidentaloma in Patients with Hepatocellular Carcinoma

  AUTHORS: Taisuke Harada, Tamotsu Kamishima, Satoshi Terae, Yuya Onodera, Hiroki Shirato

  KEYWORDS: CT; Adrenal Incidentaloma; Hepatocellular Carcinoma; Lipid-Poor Adrenal Adenomas; Metastatic Adrenal Tumors

  JOURNAL NAME: Advances in Computed Tomography, Vol.2 No.1, March 28, 2013

  ABSTRACT: We investigate the diagnostic reliability of differentiating between lipid-poor adrenal adenomas and metastatic adrenal tumors originating from hepatocellular carcinoma (HCC) using a routine dynamic CT protocol for liver imaging. Eighteen metastatic adrenal tumors originating from HCC and 13 lipid-poor adrenal adenomas were identified. Dynamic CT data were analyzed for CT attenuation of adrenal lesions before and after contrast administration. When a cutoff of 36 HU was set for adrenal lesions at pre-contrast attenuation, the sensitivity and specificity for the diagnosis of metastatic lesions were 94.4%and 92.3%, respectively. Attenuation criteria on pre-contrast CT may help optimize the differentiation between these lesions.